Records containing: Leukemia, Myelocytic, Acute
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
-
CLINICAL_TRIALS study record update · 2023-09-15Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years
-
CLINICAL_TRIALS study record update · 2023-02-16A Phase I, Dose-finding Study of the Oral, Dual Phosphatidylinositol 3(PI3)-Kinase / Mammilian Target of Rapamycin (mTOR) Inhibitor BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia
-
CLINICAL_TRIALS study record update · 2019-05-01Randomized Trial of Unmanipulated Versus Expanded Cord Blood
-
CLINICAL_TRIALS study record update · 2018-10-31Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes for Therapy of Relapsed Leukemia After Allogeneic Stem Cell Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-05-30A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN #0901)
-
CLINICAL_TRIALS study record update · 2017-11-17AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10
-
CLINICAL_TRIALS study record update · 2017-03-10A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients
-
CLINICAL_TRIALS study record update · 2016-11-07ClinicalTrials.gov study NCT00000589
-
CLINICAL_TRIALS study record update · 2016-09-09A Clinical Trial of Donor-derived WT1 Specific T Cells for Prevention of Relapse in Combination With Multiple Pathogen Specific T Cells for Prevention of Infection in Patients Undergoing Allogeneic Haemopoietic Stem Cell Transplant for AML
-
CLINICAL_TRIALS study record update · 2016-03-07A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
-
CLINICAL_TRIALS study record update · 2015-09-25Phase II Study: HSCT Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
-
CLINICAL_TRIALS study record update · 2014-11-10A Phase 2 Single Arm Trial of HLA-Matched Transplants, CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated by CliniMACS System in the Treatment of Patients With AML in 1st or 2nd Morphologic Complete Remission (BMTCTN0303)
-
CLINICAL_TRIALS study record update · 2012-12-07A Phase II Study of Parathyroid Hormone Following Myeloablative Sequential Unrelated Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2012-11-08Risk Adapted Treatment for Primary AML in Adults, Based on Genetics and Minimal Residual Disease (MRD) in Patients up to the Age of 70 Years.
-
CLINICAL_TRIALS study record update · 2012-11-01Risk Adapted Treatment for Primary AML in Adults up to the Age of 60 Years.
-
CLINICAL_TRIALS study record update · 2012-01-26Use of the MiCK Assay for Apoptosis to Predict Complete Remission in Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2012-01-19A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-03-10Multicenter Study of 9-AC in Refractory Leukemia
-
CLINICAL_TRIALS study record update · 2010-07-27Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
-
CLINICAL_TRIALS study record update · 2010-03-26A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
-
CLINICAL_TRIALS study record update · 2010-02-02Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2009-08-20A Randomized Study of Two Doses Gemtuzumab Ozogamicin vs. A Two-year Maintenance With Atra Plus Chemotherapy as Post-consolidation Treatment for Intermediate and High-risk Adult Patients With Acute Promyelocytic Leukemia (Apl)
-
CLINICAL_TRIALS study record update · 2009-07-29A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2006-11-14Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia